Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer

Marketa Skala, M. Berry, G. Duchesne, K. Gogna, Keen Hun Tai, S. Turner, A. Kneebone, A. Rolfo, A. Haworth

    Research output: Contribution to journalReview articleResearchpeer-review

    Abstract

    Three-dimensional conformal radiation therapy (3DCRT) has been shown to reduce normal tissue toxicity and allow dose escalation in the curative treatment of prostate cancer. The Faculty of Radiation Oncology Genito-Urinary Group initiated a consensus process to generate evidence-based guidelines for the safe and effective implementation of 3DCRT. All radiation oncology departments in Australia and New Zealand were invited to complete a survey of their prostate practice and to send representatives to a consensus workshop. After a review of the evidence, key issues were identified and debated. If agreement was not reached, working parties were formed to make recommendations. Draft guidelines were circulated to workshop participants for approval prior to publication. Where possible, evidence-based recommendations have been made with regard to patient selection, risk stratification, simulation, planning, treatment delivery and toxicity reporting. This is the first time a group of radiation therapists, physicists and oncologists representing professional radiotherapy practice across Australia and New Zealand have worked together to develop best-practice guidelines. These guidelines should serve as a baseline for prospective clinical trials, outcome research and quality assurance.

    LanguageEnglish
    Pages493-501
    Number of pages9
    JournalAustralasian Radiology
    Volume48
    Issue number4
    DOIs
    Publication statusPublished - Dec 2004

    Fingerprint

    New Zealand
    Prostatic Neoplasms
    Radiation Oncology
    Radiotherapy
    Guidelines
    Practice Guidelines
    Consensus Development Conferences
    Professional Practice
    Patient Selection
    Publications
    Prostate
    Outcome Assessment (Health Care)
    Clinical Trials
    Radiation
    Education
    Therapeutics

    Keywords

    • 3-D conformal therapy
    • Consensus development conference
    • Dose escalation
    • Practice guidelines
    • Prostatic neoplasms

    Cite this

    Skala, Marketa ; Berry, M. ; Duchesne, G. ; Gogna, K. ; Tai, Keen Hun ; Turner, S. ; Kneebone, A. ; Rolfo, A. ; Haworth, A. / Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer. In: Australasian Radiology. 2004 ; Vol. 48, No. 4. pp. 493-501.
    @article{c77715e809d148d682c05f73c270368b,
    title = "Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer",
    abstract = "Three-dimensional conformal radiation therapy (3DCRT) has been shown to reduce normal tissue toxicity and allow dose escalation in the curative treatment of prostate cancer. The Faculty of Radiation Oncology Genito-Urinary Group initiated a consensus process to generate evidence-based guidelines for the safe and effective implementation of 3DCRT. All radiation oncology departments in Australia and New Zealand were invited to complete a survey of their prostate practice and to send representatives to a consensus workshop. After a review of the evidence, key issues were identified and debated. If agreement was not reached, working parties were formed to make recommendations. Draft guidelines were circulated to workshop participants for approval prior to publication. Where possible, evidence-based recommendations have been made with regard to patient selection, risk stratification, simulation, planning, treatment delivery and toxicity reporting. This is the first time a group of radiation therapists, physicists and oncologists representing professional radiotherapy practice across Australia and New Zealand have worked together to develop best-practice guidelines. These guidelines should serve as a baseline for prospective clinical trials, outcome research and quality assurance.",
    keywords = "3-D conformal therapy, Consensus development conference, Dose escalation, Practice guidelines, Prostatic neoplasms",
    author = "Marketa Skala and M. Berry and G. Duchesne and K. Gogna and Tai, {Keen Hun} and S. Turner and A. Kneebone and A. Rolfo and A. Haworth",
    year = "2004",
    month = "12",
    doi = "10.1111/j.1440-1673.2004.01354.x",
    language = "English",
    volume = "48",
    pages = "493--501",
    journal = "Australasian Radiology",
    issn = "0004-8461",
    publisher = "Wiley-Blackwell, Wiley",
    number = "4",

    }

    Skala, M, Berry, M, Duchesne, G, Gogna, K, Tai, KH, Turner, S, Kneebone, A, Rolfo, A & Haworth, A 2004, 'Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer', Australasian Radiology, vol. 48, no. 4, pp. 493-501. https://doi.org/10.1111/j.1440-1673.2004.01354.x

    Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer. / Skala, Marketa; Berry, M.; Duchesne, G.; Gogna, K.; Tai, Keen Hun; Turner, S.; Kneebone, A.; Rolfo, A.; Haworth, A.

    In: Australasian Radiology, Vol. 48, No. 4, 12.2004, p. 493-501.

    Research output: Contribution to journalReview articleResearchpeer-review

    TY - JOUR

    T1 - Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer

    AU - Skala, Marketa

    AU - Berry, M.

    AU - Duchesne, G.

    AU - Gogna, K.

    AU - Tai, Keen Hun

    AU - Turner, S.

    AU - Kneebone, A.

    AU - Rolfo, A.

    AU - Haworth, A.

    PY - 2004/12

    Y1 - 2004/12

    N2 - Three-dimensional conformal radiation therapy (3DCRT) has been shown to reduce normal tissue toxicity and allow dose escalation in the curative treatment of prostate cancer. The Faculty of Radiation Oncology Genito-Urinary Group initiated a consensus process to generate evidence-based guidelines for the safe and effective implementation of 3DCRT. All radiation oncology departments in Australia and New Zealand were invited to complete a survey of their prostate practice and to send representatives to a consensus workshop. After a review of the evidence, key issues were identified and debated. If agreement was not reached, working parties were formed to make recommendations. Draft guidelines were circulated to workshop participants for approval prior to publication. Where possible, evidence-based recommendations have been made with regard to patient selection, risk stratification, simulation, planning, treatment delivery and toxicity reporting. This is the first time a group of radiation therapists, physicists and oncologists representing professional radiotherapy practice across Australia and New Zealand have worked together to develop best-practice guidelines. These guidelines should serve as a baseline for prospective clinical trials, outcome research and quality assurance.

    AB - Three-dimensional conformal radiation therapy (3DCRT) has been shown to reduce normal tissue toxicity and allow dose escalation in the curative treatment of prostate cancer. The Faculty of Radiation Oncology Genito-Urinary Group initiated a consensus process to generate evidence-based guidelines for the safe and effective implementation of 3DCRT. All radiation oncology departments in Australia and New Zealand were invited to complete a survey of their prostate practice and to send representatives to a consensus workshop. After a review of the evidence, key issues were identified and debated. If agreement was not reached, working parties were formed to make recommendations. Draft guidelines were circulated to workshop participants for approval prior to publication. Where possible, evidence-based recommendations have been made with regard to patient selection, risk stratification, simulation, planning, treatment delivery and toxicity reporting. This is the first time a group of radiation therapists, physicists and oncologists representing professional radiotherapy practice across Australia and New Zealand have worked together to develop best-practice guidelines. These guidelines should serve as a baseline for prospective clinical trials, outcome research and quality assurance.

    KW - 3-D conformal therapy

    KW - Consensus development conference

    KW - Dose escalation

    KW - Practice guidelines

    KW - Prostatic neoplasms

    UR - http://www.scopus.com/inward/record.url?scp=11144289979&partnerID=8YFLogxK

    U2 - 10.1111/j.1440-1673.2004.01354.x

    DO - 10.1111/j.1440-1673.2004.01354.x

    M3 - Review article

    VL - 48

    SP - 493

    EP - 501

    JO - Australasian Radiology

    T2 - Australasian Radiology

    JF - Australasian Radiology

    SN - 0004-8461

    IS - 4

    ER -